Welcome to our book review site go-pdf.online!
You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Neurodegenerative Diseases Biomarkers
This volume presents recent data on the latest achievements in new and emerging technologies for biomarkers and for innovations in their assessment. The chapters cover topics such as activation of microglia and macrophages in neurodegenerative diseases; oxidative stress and cellular dysfunction in neurodegenerative diseases; TSPO PET imaging as a biomarker of neuroinflammation in neurodegenerative disorders; and imaging biomarkers in Huntington's disease and amyotrophic lateral sclerosis. In the Neuromethods series style, chapters include the kind of detail and key advice from the specialists needed to get successful results in your laboratory. Cutting-edge and comprehensive, Neurodegenerative Diseases Biomarkers: Towards Translating Research to Clinical Practice is a valuable resource for both experimental and clinical experts in the field of neurodegenerative diseases who are looking to expand their knowledge of novel biomarkers in different types of neurodegenerative diseases.
MicroRNAs in Diseases and Disorders: Emerging Therapeutic Targets
From pathology to treatment, MicroRNAs in Diseases and Disorders highlights the role of microRNAs (miRNAs) in the development and progression of a variety of diseases, including cancer, neurological disease, endocrine disease and autoimmune disease, and underscores the utilization of miRNA targets in the treatment of these conditions. Providing a comprehensive account, this book also includes the identification of miRNAs as diagnostic and prognostic biomarkers for disease, as well as evaluates translational value from clinical trials using synthesized and functionalized miRNA mimics and inhibitors. With a global contribution list and chapters from leading experts across the field, MicroRNAs in Diseases and Disorders is an invaluable reference to miRNA researchers and health professionals in a variety of disease areas in government, academia and industry. The book will also appeal to pharmaceutical and medicinal chemists with an interest in miRNA targeting therapeutics, as well as to advanced students in chemical biology and drug discovery.
Traditional Chinese Medicine
Traditional Chinese medicine has a strong scientific basis, but the science of these important preparations is often rarely discussed. Western approaches often simplify traditional Chinese medicine to drug discovery in Chinese plants, however, the majority of traditional Chinese medications use complex mixtures of plant extracts, rather than single purified drugs. The combination of different extracts is based on yin, yang and chi theories, which are often poorly understood in the West. Yin and yang are known to be the balance of agonists and antagonists, whereas chi derives from signalling processes in the body and regulates bodily functions. Traditional Chinese medical practitioners unders...
Proceedings of Light-Activated Tissue Regeneration and Therapy Conference
This book is the first to present the mechanism which explains why light is an effective treatment for so many illnesses and diseases. The book not only explains this mechanism, but describes uses for the mechanism, as well as what new work is planned and what changes will be seen in FDA regulations. Extensive papers and coverage on many interesting topics are included.
World Economic and Social Survey 2018
This publication reviews the advances in frontier technologies including automation, robotics, renewable energy technologies, electric vehicles, biotechnologies and artificial intelligence and analyzes their economic, social and environmental impact. These technologies present immense potentials for the 2030 Agenda, fostering growth, prosperity and environmental sustainability. They also pose significant risks of unemployment, underemployment and rising income and wealth inequality and raise new ethical and moral concerns. The Survey identifies policy measures at national levels with the capacity to both maximize the potential of these technologies and mitigate their risks, thereby striking a balance among economic efficiency, equity and ethical considerations
